Assessment of the anti-anaemic activity of a ready-to-serve beverage developed from sharbat-e-gudhal (a traditional hibiscus rosa-sinensis syrup) in comparison with traditional sharbat-e-gudhal and ferrous sulphate supplementation in patients with mild iron-deficiency anaemia
| ISRCTN | ISRCTN16279156 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN16279156 |
| Sponsor | University of Sri Jayewardenepura |
| Funder | Investigator initiated and funded |
- Submission date
- 03/07/2026
- Registration date
- 08/07/2026
- Last edited
- 15/09/2026
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Haematological Disorders
Plain English summary of protocol
Not provided at time of registration
Contact information
Principal investigator, Scientific, Public
No. 50 St. Lazarus Road, Periyamulla
Negombo
11500
Sri Lanka
| 0009-0001-0963-2528 | |
| Phone | +94 (0)773016949 |
| rizniyamnf@fim.cmb.ac.lk |
Scientific
Department of Pathology, Faculty of Medical Sciences, University of Sri Jayewardenepura
Sri Jayewardenepura
10100
Sri Lanka
| 0000-0002-0024-5054 | |
| Phone | +94 (0)777746864 |
| fernandopulle@sjp.ac.lk |
Scientific
Department of Pharmacology, University of Sri Jayewardenepura
Sri Jayewardenepura
10100
Sri Lanka
| 0009-0004-8937-1488 | |
| Phone | +94 (0)712304322 |
| pradeepa@sjp.ac.lk |
Scientific
Faculty of Indigenous Medicine, University of Colombo, Rajagiriya
Sri Jayewardanapura
10100
Sri Lanka
| 0000-0003-0337-1336 | |
| kamalperea@fim.cmb.ac.lk |
Public, Scientific
Faculty of Indigenous Medicine, University of Colombo, Rajagiriya
Sri Jayewardanapura
10100
Sri Lanka
| Phone | +94 (0)714422394 |
|---|---|
| drmawjood@fim.cmb.ac.lk |
Study information
| Primary study design | Interventional |
|---|---|
| Allocation | Randomized controlled trial |
| Masking | Open (masking not used) |
| Control | Active |
| Assignment | Parallel |
| Purpose | Treatment |
| Scientific title | Efficacy and safety of a ready-to-serve beverage derived from sharbat-e-gudhal (a traditional syrup of China rose-unani formula used in faqrud dam [anemia]) in the management of mild iron-deficiency anaemia: a randomized controlled trial |
| Study objectives | To comparatively evaluate efficacy and safety of a ready-to-serve (RTS) beverage derived from sharbat e gudhal and sharbat e gudhal (the traditional syrup) with standard iron supplements in patients with mild iron deficiency anaemia. |
| Ethics approval(s) |
Approved 29/04/2026, Ethical Review Committee, Faculty of Indigenous Medicine (University of Colombo, Rajagiriya, Colombo, 10100, Sri Lanka; +94 (0)112692385; ethicsreview@fim.cmb.ac.lk), ref: ERC 24/265 |
| Health condition(s) or problem(s) studied | Anaemia |
| Intervention | Recruited patients will be asked to visit the clinic periodically as the instructions given by the principal investigator (3 weeks after the first visit, with completion of the first month and monthly thereafter). Participants will be assigned to test groups I and II and the control group as described below. Group I: 150 ml of RTS beverage from sharbat-e-gudhal given at 10:00 am as a snack Group II: Sharbat-e-gudhal given as 25 ml in the morning and 25 ml at night before meals Control group: one tablet of ferrous sulphate (200 mg) with one tablet of vitamin C (100 mg) at night 2 hours before dinner Randomization will be done using computer-generated random numbers that are obtained using Research Randomizer. Duration of protocol therapy: 120 days The patients will be assessed subjectively and by objective parameters on days 0 (baseline), 21, 90, and 120. On these days a questionnaire will be administered to them by the investigators to collect data on their views regarding the improvement of symptoms on treatment and to detect any adverse effects of the treatment. Further, a blood sample (5 ml) will be taken for the required analysis by a qualified phlebotomist (nurse/medical lab technician). The blood tests will be performed at an accredited laboratory |
| Intervention type | Drug |
| Phase | Phase II |
| Drug / device / biological / vaccine name(s) | RTs beverage derived from sharbat-e-gudhal |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) |
1. Liver function (serum glutamic oxaloacetic transaminase [SGOT], serum glutamic-pyruvic transaminase [SGPT] and serum bilirubin levels) measured using the automated biochemistry analyzer at baseline, 21st, 90th and 120th days |
| Completion date | 14/03/2028 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 18 Years |
| Upper age limit | 65 Years |
| Sex | All |
| Target sample size at registration | 114 |
| Key inclusion criteria | 1. Mild anaemic patients 2. Either sex 3. Aged 18 to 65 years 4. Patients with confirmed mild iron deficiency anaemia with the following limits: 4.1. Hb%: female: ≥9 g/dl and ≤12 g/dl; male: ≥9 g/dl and ≤13 g/dl 4.2. Serum ferritin: ≤30 µg/l |
| Key exclusion criteria | 1. Patients below 18 years and above 65 years of age 2. Moderate to severe anaemia (Hb%: ≤9 g/dl) 3. Patient with concurrent respiratory diseases, cardiovascular diseases, liver diseases and renal diseases 4. Pregnant and lactating women 5. Patients with a history of diabetes mellitus |
| Date of first enrolment | 10/09/2026 |
| Date of final enrolment | 31/10/2027 |
Locations
Countries of recruitment
- Sri Lanka
Study participating centre
Colombo
Sri Lanka
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan | The datasets generated during and/or analysed during the current study are/will be available upon request from Dr MNF Rizniya (rizniyamnf@fim.cmb.ac.lk). Study participant data sheets will not include contact or identifying details. Study data entry and study management systems used by clinical sites will be secured and password protected. At the end of the study, all study databases will be de-identified and archived. Availability of raw data of the study is based on the above conditions. |
Editorial Notes
15/09/2026: The date of first enrolment was changed from 01/08/2026 to 10/09/2026.
13/07/2026: Contact details updated.
03/07/2026: Study's existence confirmed by the University of Sri Jayewardenepura.